Commentary on Perez et al.: How to Create a 21(st) Century Adverse Event Reporting System

by Sharon, Elad
Published in Clin Trials (2017)

Can an immune checkpoint inhibitor (sometimes) make things worse?

by Sharon, Elad
Published in Clin Cancer Res (2017)

Fibulin-3 as a Biomarker for Pleural Mesothelioma

by Hollevoet, Kevin, Sharon, Elad
Published 2013

PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma

by Curran, Colleen S., Sharon, Elad
Published in Semin Oncol (2018)

IGF-1R as an anti-cancer target—trials and tribulations

by Chen, Helen X., Sharon, Elad
Published 2013

Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States

by Enewold, Lindsey, Sharon, Elad, Thomas, Anish
Published in Lung Cancer (2017)

Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine

by Sharon, Elad, Kelly, Ronan J, Szabo, Eva
Published 2010

Chemotherapy and Targeted Therapies for Unresectable Malignant Mesothelioma

by Kelly, Ronan Joseph, Sharon, Elad, Hassan, Raffit
Published 2011

Metastatic melanoma: treatment and survival in the US after the introduction of ipilimumab and vemurafenib

by Enewold, Lindsey, Sharon, Elad, Harlan, Linda C
Published in Oncol Res Treat (2017)

PD-1 immunobiology in systemic lupus erythematosus

by Curran, Colleen S., Gupta, Sarthak, Sanz, Ignacio, Sharon, Elad
Published in J Autoimmun (2018)

Mesothelin targeted agents in clinical trials and in preclinical development

by Kelly, Ronan J., Sharon, Elad, Pastan, Ira, Hassan, Raffit
Published 2012

Immune checkpoint inhibitors in clinical trials

by Sharon, Elad, Streicher, Howard, Goncalves, Priscila, Chen, Helen X.
Published 2014

Thyroid Cancer Presentation and Treatment in the United States

by Enewold, Lindsey, Harlan, Linda C., Stevens, Jennifer L., Sharon, Elad
Published in Ann Surg Oncol (2014)

Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome

by Geisler, Benjamin P, Raad, Roy A, Esaian, Diana, Sharon, Elad, Schwartz, David R
Published in J Immunother Cancer (2015)

Report on the 2018 Cancer, Autoimmunity, and Immunology Conference

by Curran, Colleen S., Sommers, Connie L., Young, Howard A., Bourcier, Katarzyna, Mancini, Marie, Sharon, Elad
Published in J Immunol (2019)

Incidence and survival of rare cancers in the US and Europe

by Botta, Laura, Gatta, Gemma, Trama, Annalisa, Bernasconi, Alice, Sharon, Elad, Capocaccia, Riccardo, Mariotto, Angela B.
Published in Cancer Med (2020)

Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls

by Venkatesulu, Bhanu P, Lester, Scott, Hsieh, Cheng-En, Verma, Vivek, Sharon, Elad, Ahmed, Mansoor, Krishnan, Sunil
Published in JNCI Cancer Spectr (2020)

ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic

by Braun, Maya, Sharon, Elad, Unterman, Irene, Miller, Maya, Shtern, Anna Mellul, Benenson, Shmuel, Vainstein, Alexander, Tabach, Yuval
Published in iScience (2020)

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

by Spillane, Susan, Baxi, Shrujal, Torres, Aracelis Z., Lenis, David, Freedman, Andrew N., Mariotto, Angela B., Sharon, Elad
Published in Oncologist (2020)

Ocular adverse events in PD-1 and PD-L1 inhibitors

by Young, LeAnne, Finnigan, Shanda, Streicher, Howard, Chen, Helen X, Murray, James, Sen, H Nida, Sharon, Elad
Published in J Immunother Cancer (2021)